New drugs should be compared with existing treatments before approval, say experts
Tuesday, September 6, 2011 - 19:30
in Health & Medicine
Manufacturers should have to show how their drugs compare to existing treatments before approval to help ensure that the most beneficial and safest therapies reach patients and that limited healthcare resources are invested wisely, argue experts in a new article.